Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01068119 · ClinicalTrials.gov registry record · Phase 4
Same-Day Discharge After Coronary Percutaneous Transluminal Coronary Angioplasty (PTCA)
A Phase 4 study, sponsored by Piedmont Healthcare.
- Terminated
- Registry status
- Phase 4
- Development phase
- 57
- Enrollment target
NCT01068119 is a Phase 4 study that was terminated before completion, run by Piedmont Healthcare. The registered enrollment target is 57 participants.
The verdict
NCT01068119, a Phase 4 study, was terminated before completion, sponsored by Piedmont Healthcare.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 57 participants
- Enrollment target
Study Summary
Same day discharge is safe and feasible in selected troponin negative patients undergoing coronary planned percutaneous coronary intervention (PCI) or ad hoc PCI via the transfemoral approach.
Interventions
- PROCEDURE Same-day discharge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2010-02 |
| Est. Completion | 2012-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01068119
The ClinicalTrials.gov registry entry for NCT01068119 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Piedmont Healthcare, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Same-day discharge is the first listed.
NCT01068119 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01068119 about?
NCT01068119 is a clinical study titled "Same-Day Discharge After Coronary Percutaneous Transluminal Coronary Angioplasty (PTCA)". Same day discharge is safe and feasible in selected troponin negative patients undergoing coronary planned percutaneous coronary intervention (PCI) or ad hoc PCI via the transfemoral approach.
What is the current status of trial NCT01068119?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 57 participants. The study started on 2010-02. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01068119?
The interventions under investigation include: Same-day discharge (PROCEDURE).
Who is sponsoring clinical trial NCT01068119?
This trial is sponsored by Piedmont Healthcare, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.